VC
ABBV icon

Voit & Company’s AbbVie ABBV Stock Holding History

Voit & Company’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,900
Closed -$13K – 64
2019
Q3 		$13K Buy
+1,900
New +$130K 0.01% 63

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Voit & Company's ABBV Position: Q3 2020 in Review

Voit & Company increased its AbbVie (ABBV) stake by 1% in Q3 2020, buying an estimated $47.4K and bringing the position to 50,437 shares worth $4.42M. The position accounts for 4.27% of the portfolio, ranked #10.

Voit & Company first reported a position in ABBV in Q4 2018 and has held it in 8 quarters since. The position peaked at $4.9M in Q2 2020. 2,367 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

  • Voit & Company held 50,437 shares of AbbVie worth $4.42M as of Q3 2020.
  • Voit & Company bought 503 AbbVie shares in Q3 2020, an estimated $47.4K.
  • AbbVie made up 4.27% of Voit & Company's portfolio in Q3 2020, its #10 holding.
  • Voit & Company first reported a position in AbbVie in Q4 2018 and has held it in 8 quarters since.
  • Voit & Company's AbbVie position peaked at $4.9M in Q2 2020.
  • 2,367 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on Voit & Company's 13F filing for Q3 2020, filed 30 Oct 2020.